A subsequent analysis of these data identified a nested cohort of patients with ARDS treated with BM-MSCs who presented a significant reduction of airspace total protein, Ang-2, IL-6, and TNF-R1 levels within 48 h after infusion of BM-MSCs (Wick et al., 2021). Here, IL6 is linked to acute respiratory distress syndrome.